Laboratorios Farmaceuticos ROVI Stock

Laboratorios Farmaceuticos ROVI Book Value per Share

The Book Value per Share of Laboratorios Farmaceuticos ROVI (ROVI.MC) as of Aug 21, 2026 is 12.97 EUR. In the previous year, Book Value per Share was 11.17 EUR — a change of 16.15% (higher).

Book Value per Share

12.97EUR

YoY

16.15%

Last updated:

Book Value per Share of Laboratorios Farmaceuticos ROVI is 2026 12.97 EUR. Book Value per Share of Laboratorios Farmaceuticos ROVI was 2025 11.17 EUR. It decreases by 16.15% higher compared to the previous year.
Access this data via the Eulerpool API

Laboratorios Farmaceuticos ROVI Stock analysis

What does Laboratorios Farmaceuticos ROVI do? Laboratorios Farmaceuticos ROVI SA is a Spanish pharmaceutical company that was founded in 1946 by Salvador and Ignacio Ruiz-Salmones. The company is headquartered in Madrid and employs over 1,000 employees. ROVI manufactures a variety of pharmaceutical products and offers services in various areas. The company specializes in the development and manufacturing of specialty preparations in the fields of oncology, hematology, endocrinology, and gastroenterology. The company operates in three business areas: specialty pharmaceuticals, contrast agents, and active ingredients for the industry. The specialty pharmaceuticals business area includes medications for various applications, such as the treatment of cancer, blood disorders, endocrine disorders, gastroenterological disorders, and central nervous system disorders. The contrast agents division produces products for radiology and diagnostics. The products are used in various medical fields, from cardiology to gastroenterology. In the active ingredients for the industry business area, ROVI manufactures active ingredients for other pharmaceutical companies. ROVI specializes in the production of specialty products and relies on collaborations with other companies. The company has strategic partnerships with many companies such as GlaxoSmithKline, Pfizer, Sanofi-Aventis, and Zeltia. This also includes some research collaborations to develop and market products together. The company is also dedicated to the development of biosimilars, which allow for the offering of biologic drugs at a lower price. Biosimilars are copies of biopharmaceuticals that are usually very expensive due to the complex manufacturing process and high development costs. ROVI is also a major producer of vaccines that are distributed worldwide. ROVI has followed a solid growth trajectory in recent years. The company has been able to consistently increase its revenue and profit and is now a major player in the pharmaceutical industry. The company also operates a strong research and development department that constantly develops new products and technologies to improve patient care. In summary, Laboratorios Farmaceuticos ROVI SA is a leading pharmaceutical company specializing in the manufacturing of specialty products. With its subsidiaries in Europe and the USA, ROVI has an international presence and has made a name for itself through its expertise in the development and manufacturing of innovative pharmaceutical products. Laboratorios Farmaceuticos ROVI is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Laboratorios Farmaceuticos ROVI stock

Book Value per Share of Laboratorios Farmaceuticos ROVI is 12.97 EUR in 2026.

Book Value per Share of Laboratorios Farmaceuticos ROVI changed from 11.17 EUR to 12.97 EUR, representing a 16.15% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Laboratorios Farmaceuticos ROVI since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

Balance Sheet — Laboratorios Farmaceuticos ROVI

All Key Metrics — Laboratorios Farmaceuticos ROVI